tradingkey.logo


tradingkey.logo


Check Cap Ltd

CHEK

詳现チャヌトを衚瀺
1.610USD
0.0000.00%
終倀 02/06, 16:00ET15分遅れの株䟡
9.42M時䟡総額
損倱額盎近12ヶ月PER

Intraday
1m
30m
1h
D
W
M
D

本日

0.00%

5日間

0.00%

1ヶ月

0.00%

6ヶ月

+166.56%

幎初来

0.00%

1幎間

+82.93%

詳现チャヌトを衚瀺

TradingKey 株匏スコア

デヌタが䞍十分なため、株匏スコアは利甚できたせん。

Check Cap Ltd ニュヌス

最新情報をお埅ちください...

財務指暙

EPS

䌚瀟から関連デヌタがただ開瀺されおいたせん。

総売䞊高

䌚瀟から関連デヌタがただ開瀺されおいたせん。

Check Cap Ltdの䌁業情報

Check Cap Ltd is an Israel-based clinical-stage medical diagnostics company. Check Cap Ltd develops C-Scan, patient-friendly preparation-free test designed to detect polyps before they may transform into cancer to enable early intervention and cancer prevention. It's capsule-based screening technology aims to increase screening adherence worldwide. The system utilizes ultra-low-dose X- rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities. C-Scan is non-invasive capsule that is propelled through the gastrointestinal tract by natural motility. C-Scan is comprised of three main components: C-Scan Cap, an ingestible X-ray scanning capsule; C-Scan Track, three miniaturized patches worn on the patient’s back for integrated positioning, control and data recording; and C-Scan View, a proprietary software to process and represent 2D and 3D maps of the inner surface of the colon.
䌁業コヌドCHEK
䌁業名Check Cap Ltd
最高経営責任者「CEO」Ovadia (Alex)
りェブサむトhttps://check-cap.com/
KeyAI
î™